NCT06426212View on ClinicalTrials.gov

Use of Teicoplanin on a Three-weekly Administration in the Infectious Diseases Unit

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

May 7, 2024

Primary Completion Date

May 31, 2024

Study Completion Date

June 30, 2024

Conditions
Comparison of Teicoplanin Used Three Times a Week in DSIs vs NDISs
Interventions
DRUG

Use of teicoplanin three times a week

retrospective study to evaluate the clinical effectiveness of teicoplanin therapy according to a three-weekly scheme comparing its use in the treatment of deep infections (deep seated infections - DSIs) and superficial infections (non-deep seated infections - NDSIs).

Trial Locations (1)

23900

RECRUITING

Stefania Piconi, Lecco

All Listed Sponsors
lead

Azienda Ospedaliera di Lecco

OTHER